ClinicalTrials.gg
RecruitingNCT07607795GRIP4HEALTHUpdated May 26, 2026

Effect of Isometric Handgrip Exercise on Blood Pressure in Pregnant Women

An interventional study of Isometric Handgrip Exercise and Control Rest in Pregnancy, Pregnancy - Prenatal Testing and Hypertension (HTN), sponsored by University of Poitiers. Recruiting at 1 site in France. Open to female participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-05-26.

Sponsored by University of Poitiers · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Started Mar 2026; still recruiting 8 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 211 studies in Hypertension with a site in France — 33 open to participants now, 46 under way, 6 of them phase 3. Hypertension · France.

Planned enrollment
134th of 152
30 · median 272
Started
2026
with 8 others
No phase
62 of 211
13 open now
Primary completion
2027-08
later than 27 of 45 live
Registered
206th of 211
by date

Among the 211 studies in Hypertension with a site in France, this one is the 134th largest by planned enrollment of the 152 interventional ones that give a count, is one of 9 that started in 2026, is one of 62 with no phase, reaches primary completion later than 27 of the 45 other live ones, and was the 206th registered.

Hypertension

6,128 studies on the registry are indexed under Hypertension; 907 are open to participants now.

Browse Hypertension studies →

Open to participants now

33 of the 211 studies in Hypertension with a site in France are open now. Recruiting first, the newest first:

27 more — sign in →

All 33 open studies →

A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →

Who these studies take

Of the 552 Hypertension studies recruiting now, 260 (47%) set no upper age limit and 198 (36%) stop at 75 or younger; 40 take children under 18; 136 take healthy volunteers.

This study: 18 Years to 45 Years · female · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 211 studies in Hypertension with a site in France, or all of them as a file.
02

Study summary

Hypertension during pregnancy is a major public health concern, increasing the risk of cardiovascular complications for both the mother and the fetus. Women with chronic hypertension are at higher risk of adverse outcomes, and elevated blood pressure during pregnancy has also been associated with long-term cardiovascular and cognitive impairments.Regular physical activity is recognized as an effective non-pharmacological strategy to reduce blood pressure. Among different exercise modalities, isometric exercise has shown promising effects in lowering blood pressure in the general population, with minimal cardiovascular strain. However, its effects and safety in pregnant women, particularly those with hypertension, remain poorly understood.In addition to cardiovascular alterations, hypertension during pregnancy may also impact cognitive function, potentially through changes in cerebral perfusion and vascular function. Despite these associations, the combined cardiovascular and cognitive responses to exercise in this population have not been fully explored.This study aims to investigate the effects of isometric handgrip exercise on cardiovascular and cognitive responses in pregnant women with and without chronic hypertension, in order to better understand its potential as a safe and effective non-pharmacological intervention during pregnancy.

Read the detailed description

Hypertension during pregnancy is a major public health concern associated with increased maternal and fetal morbidity, and long-term cardiovascular risk. Women with chronic hypertension are at higher risk of complications such as preeclampsia, preterm birth, and adverse neonatal outcomes. In addition, growing evidence suggests that hypertensive disorders of pregnancy may also be associated with long-term alterations in cardiovascular function and cognitive performance.During pregnancy, physiological changes in blood pressure regulation and vascular function may further complicate the management of hypertension. Pharmacological treatment options are limited due to potential risks for the fetus, highlighting the need for safe and effective non-pharmacological strategies.Physical exercise is recognized as an effective approach to reduce blood pressure and improve cardiovascular health in the general population. Among the different exercise modalities, isometric exercise has shown particularly promising effects in reducing blood pressure, with a low cardiovascular load. This modality may therefore represent an attractive option for pregnant women, as it can be performed safely with minimal physiological stress. However, despite these potential benefits, the effects and safety of isometric exercise during pregnancy, particularly in hypertensive women, remain poorly understood.In addition to cardiovascular alterations, hypertension during pregnancy may impact cognitive function, potentially through changes in cerebral perfusion and vascular regulation. Although physical activity has been associated with improvements in cognitive performance in the general population, the acute effects of exercise on cognitive function during pregnancy have not been well established.The aims of this study are:First, to evaluate the effect of isometric handgrip exercise on 24-hour blood pressure in pregnant women with and without chronic hypertension.Second, to compare cardiovascular responses to isometric exercise between normotensive and hypertensive pregnant women, including brachial and central blood pressure, arterial stiffness, and heart rate.Third, to examine differences in cognitive performance between normotensive and hypertensive pregnant women, and to explore the relationship between cardiovascular responses and cognitive outcomes.

03

Conditions studied

  • Pregnancy
  • Pregnancy - Prenatal Testing
  • Hypertension (HTN)

Browse trials for

Keywords

  • Isometric Exercise
  • Handgrip Exercise
  • Blood Pressure
  • Ambulatory Blood Pressure Monitoring
  • Pregnancy
  • Hypertension
  • Arterial Stiffness
  • Cognitive Function
04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Pregnant women covered by the French National Health Insurance system
  • Pregnant women who do not object to participation in the study
  • Women belonging to one of the following two groups:
  • Women with chronic hypertension present before pregnancy (diagnosed within the past 5 years), defined as systolic blood pressure (SBP) ≥ 140 mmHg or diastolic blood pressure (DBP) ≥ 90 mmHg, without antihypertensive treatment
  • Normotensive pregnant women, defined as systolic blood pressure (SBP) \< 140 mmHg and diastolic blood pressure (DBP) \< 90 mmHg before pregnancy

Exclusion criteria

Exclusion Criteria:

  • Current treatment for chronic or gestational hypertension
  • Known cardiovascular disease other than chronic hypertension
  • Age under 18 years
  • Persons deprived of liberty
  • Inability to speak or adequately understand French
  • Persons hospitalized without consent who are not subject to legal protection measures, and persons admitted to a health or social institution for purposes other than research
  • Persons currently excluded from participation in another research study
  • Persons under judicial protection or guardianship Type 1 or type 2 diabetes
  • Severe or extreme obesity ( ≥ 40 kg/m²)
  • Thyroid disease
  • Heavy smoking
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
30 participants (estimated)

Study arms

  • Other
    Normotensive Pregnant Women

    Pregnant women without chronic hypertension. Participants in this arm complete both the isometric handgrip exercise session and the control rest session in randomized order.

    Behavioral: Isometric Handgrip Exercise · Behavioral: Control Rest

  • Other
    Hypertensive Pregnant Women

    Pregnant women with chronic untreated hypertension. Participants in this arm complete both the isometric handgrip exercise session and the control rest session in randomized order.

    Behavioral: Isometric Handgrip Exercise · Behavioral: Control Rest

Interventions

  • BehavioralIsometric Handgrip Exercise

    Isometric handgrip exercise performed at 30% of maximal voluntary contraction, consisting of four 2-minute contractions with one-minute rest intervals between efforts. The exercise is performed using a handgrip dynamometer.

  • BehavioralControl Rest

    Seated rest condition without exercise, used as a control comparison to the isometric handgrip intervention.

06

What researchers measure

Primary outcomes

  1. Systolic and diastolic blood pressure (ambulatory blood pressure measurement)

    Post-exercise hypotension, using the Mobil-O-Graph (mmHg).

    Time frame: After sessions (24 hours)

Secondary outcomes

  1. Systolic and diastolic blood pressure (resting)

    Automated oscillometric tensiometer (mmHg)

    Time frame: Before and after sessions (15 minutes)

  2. Central blood pressure

    Central systolic and diastolic blood pressure assessed using pulse wave analysis derived from brachial oscillometric measurements.

    Time frame: Baseline and post-intervention during sessions (30 minutes)

  3. Pulse wave velocity

    Arterial stiffness assessed by carotid-femoral pulse wave velocity using applanation tonometry. This measurement is performed at rest to characterize vascular health.

    Time frame: Baseline

  4. Heart rate

    Heart rate measured during each experimental session and recovery period using a heart rate monitor to assess cardiovascular response to the intervention.

    Time frame: Basline, before and after sessions (15 minutes)

  5. Cognitive Performance

    Cognitive performance assessed at rest using a neuropsychological test battery including executive function, memory, attention, and processing speed tests. This outcome is used to compare cognitive function between normotensive and hypertensive pregnant women. * Stroop : higher scores indicate better executive function and inhibitory control. No universal minimum or maximum score. * Verbal Fluency Test: higher scores indicate better verbal executive functioning. No universal maximum score. * Rey Auditory Verbal Learning Test (RAVLT): Higher scores indicate better verbal learning and memory. Minimum score = 0; maximum score = 75. * Digit Span Test (forward and backward): higher scores indicate better working memory and attention. Minimum score = 0; No universal maximum score.

    Time frame: Baseline

07

Study locations

1 of 1 sites recruiting
  • Faculty of Sport Science - MOVE Laboratory - UR 20296
    Poitiers, 86000, France
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2026 (actual). Primary completion is estimated for Aug 2027, 17 months after the start.

Of 1,407 non-industry interventional studies with no phase under Hypertension, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 41. This study's planned 17 months is below that.

Counting every sponsor, half of 1,502 studies reached it within 23 months; a quarter within 10 and three quarters within 42.

How these figures are worked out, and which studies are left out of them.

Registered
May 6, 2026
First posted
May 26, 2026
StartActual
Mar 6, 2026
Primary completionEst.
Aug 31, 2027
CompletionEst.
Sep 30, 2027
Last update
May 26, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 26, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07607795
Lead sponsor
University of Poitiers
Collaborators
Poitiers University Hospital, Laboratory MOVE, Faculty of Sport Sciences, University of Poitiers, France
Responsible party
Carina Enea (Dr, University of Poitiers) — Principal investigator
First posted
May 26, 2026
Start date
Mar 6, 2026
Primary completion
Aug 31, 2027 (estimated)
Completion
Sep 30, 2027 (estimated)
Last update
May 26, 2026

Study contacts

Carina ENEA
Contact
carina.enea@univ-poitiers.fr
+33 549 454 495
Mélanie Gréau Marias
Contact
melanie.greau.marias@univ-poitiers.fr
+33 675 329 599

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion